businesswire.com · 29 jun

Crane Company Announces Date for Second Quarter 2026 Earnings Release and Teleconference

STAMFORD, Conn.--(BUSINESS WIRE)--Crane Company (NYSE: CR) announces the following schedule and teleconference information for its second quarter 2026 earnings release: Earnings Release: July 28, 2026 after close of market by public distribution and the Crane Company website at www.craneco.com. Teleconference: July 29, 2026 at 10:00 AM (Eastern) hosted by Alex Alcala, President & CEO, and Richard A. Maue, Executive Vice President & CFO. The call can be accessed in a listen-only mode via.

thenewswire.com · 29 jun

Headwater Gold Announces Commencement of Centerra-Funded Drilling at Crane Creek Project, Idaho

Vancouver, British Columbia – TheNewswire - June 29, 2026: Headwater Gold Inc. (CSE: HWG) (OTCQX: HWAUF) (the “Company” or “Headwater”) is pleased to announce that Centerra Gold Inc. (“Centerra”) (TSX: CG) has commenced drilling at Headwater's Crane Creek Project (“Crane Creek” or the “Project”) in western Idaho. The drill program is being operated and fully funded by Centerra pursuant to the earn-in agreement announced on December 3, 2025 . Highlights:

prnewswire.com · 18 jun

BRIXMOR PROPERTY GROUP ISSUES ANNUAL CORPORATE RESPONSIBILITY REPORT

NEW YORK, June 18, 2026 /PRNewswire/ -- Brixmor Property Group Inc. (NYSE: BRX) ("Brixmor" or the "Company") announced today the release of its eighth annual Corporate Responsibility (CR) Report, which provides a comprehensive overview of the Company's CR strategy, initiatives, and 2025 performance. "This report highlights how central Corporate Responsibility is to how we operate and grow," stated Brian Finnegan, Chief Executive Officer and President.

gurufocus.com · 15 jun

enGene Reports Second Quarter 2026 Financial Results and Provides Business Update

enGene Therapeutics Inc. (Nasdaq: ENGN, “enGene” or the “Company”), a clinical-stage, non-viral genetic medicines company today announced its financial

gurufocus.com · 13 jun

Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

[url="]Genmab A/S[/url] (Nasdaq: GMAB) today announced new data from two studies evaluating epcoritamab, a T-cell engaging antibody administered subcutaneously

zacks.com · 27 may

Implied Volatility Surging for Crane Company Stock Options

Investors need to pay close attention to CR stock based on the movements in the options market lately.

gurufocus.com · 16 may

ImmunityBio Signs Exclusive U.S. Agreement with Japan BCG Laboratory for the Tokyo Strain of BCG to Enhance BCG Supply in the United States

ImmunityBio, Inc. ([url="]NASDAQ: IBRX[/url]), a commercial-stage immunotherapy company, today announced an exclusive U.S. Development and Supply Agreement wit

gurufocus.com · 15 may

Crane Co (CR) Stock Down 4.1% -- Now Undervalued? GF Score: 86/100

On May 15, 2026, Crane Co (CR) shares fell 4.1% to a current price of $172.19. This decline comes in the context of a 52-week range that saw a high of $214.31 a